India Cystoscopy and Ureteroscopy Market Size, Share - 2031
The India cystoscopy and ureteroscopy market size is projected to reach US$ 313.63 million by 2031 from US$ 180.00 million in 2023. The market is expected to register a CAGR of 7.2% during 2023–2031. The increasing inclination towards robotic-assisted urological procedures is likely to bring new trends in the market in the coming years.
India Cystoscopy and Ureteroscopy Market Analysis
Cystoscopy and ureteroscopy are medical procedures used to examine and treat conditions of the urinary tract, focusing on different areas of the urinary system. Cystoscopes and ureteroscopes consist of thin, flexible or rigid tubes with light and a camera attached to them, which help in the visualization of the interior of bladder and urethra for the treatment and diagnosis of urinary disorders. The market is mainly driven by the increasing prevalence of urological diseases and the development of technologically advanced and minimally invasive products. Additionally, the growing medical tourism industry in India is expected to create ample opportunities in the coming years.
India Cystoscopy and Ureteroscopy Market Overview
The Indian government's initiatives such as Ayushman Bharat and the National Health Mission (NHM) are contributing significantly to the growth of the cystoscopy and ureteroscopy market. These programs focus on improving healthcare access, especially in rural areas, through the development of new healthcare centers, upgrades in existing facilities, and expansion of insurance coverages. These efforts have led to an increase in the awareness of specialized urological procedures such as cystoscopy (used for diagnosing bladder and urinary tract conditions) and ureteroscopy (used to treat kidney stones and other urological issues), particularly in rural areas where previously access to such services was limited.
The growth of medical tourism in India is further propelling the cystoscopy and ureteroscopy market. India is now a preferred destination for affordable, high-quality urological care, attracting international patients due to its advanced medical technologies and cost-effective treatment options. Hospital chains such as Apollo, Fortis, and Max Healthcare are capitalizing on this trend, with an upsurge in international patient footfall. These hospitals are also focusing on expanding their global outreach by establishing international offices that provide assistance with visa processes and travel arrangements, and make comprehensive treatment plans. According to the India Brand Equity Foundation 2024 report, Max Healthcare reported a remarkable 27% year-on-year growth in international patient revenue. Apollo Hospitals, a renowned choice for international patients, is targeting double-digit growth and plans to expand its global reach in the coming years.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
India Cystoscopy and Ureteroscopy Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
India Cystoscopy and Ureteroscopy Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystIndia Drivers and Opportunities
Increasing Prevalence of Urological Diseases Fuels India
Kidney stones, bladder cancer, prostate enlargement, urinary tract infections (UTIs), and other medical conditions related to the bladder and kidneys are common in India. The rising incidence can be associated with population aging, lifestyle factors, and genetic predispositions. As per the 2023 study "Risk Factors of Incident Kidney Stones in Indian Adults: A Hospital-Based Cross-Sectional Study," the prevalence of kidney stones in India is approximately 12%, and it is relatively higher in the northern part of India, i.e., 15%. In addition, India has a large number of patients with prostate-related issues and bladder cancer. As per the GLOBOCAN report, there were 37,948; 22,548; and 17,480 prostate, bladder, and kidney cancer cases, respectively, in India in 2022. These conditions often require diagnostic and therapeutic interventions such as cystoscopy and ureteroscopy. Cystoscopy allows examination of the urinary bladder, whereas ureteroscopy allows diagnosis and treatment of ureter and kidney conditions. Thus, these techniques are employed in stone removal and tumor diagnosis procedures, among others. These tools are widely adopted owing to their ease and effectiveness in diagnosing and treating urological conditions. Thus, the increasing prevalence of urological disorders is a significant factor driving the India growth.
Growing Medical Tourism Industry to Create Growth Opportunities
India has emerged as one of the most popular medical tourism destinations in the world, particularly for the diagnoses and treatments of urological conditions. The country's healthcare system is renowned for its high-quality services at a fraction of the costs incurred in Western countries. International patients, particularly from regions such as the Middle East, Africa, and Southeast Asia, are increasingly choosing India for their medical treatments due to the affordability, quality of care, and availability of advanced medical technology. As per the India Tourism Statistics 2023, in 2022, there were 6.43 million Foreign Tourist Arrivals (FTAs) in India; 7.4% of these FTAs traveled for medical purposes. The Government of India recognizes the potential of medical tourism, and it has introduced various initiatives to promote its growth. These initiatives include the issuance of medical visas for foreign patients, partnerships with international hospitals, and the establishment of dedicated medical tourism facilitation centers. In 2024, the government launched an initiative called Heal in India as an effort to further boost its medical tourism. The Ministry of Health and Family Welfare, the Government of India, and the Ministry of Ayush have been collaborating with the Centre for Development of Advanced Computing and the Services Export Promotion Council to propel this initiative through the "One Step Heal" portal. Additionally, many top-tier Indian hospitals and healthcare institutions are accredited by international organizations such as the Joint Commission International (JCI), further enhancing the country's reputation as a healthcare hub.
Cystoscopy and ureteroscopy are among the most sought-after procedures by medical tourists seeking treatment for urological conditions such as kidney stones, bladder cancer, and prostate problems. The availability of state-of-the-art equipment and skilled urologists also makes the country an attractive destination for these procedures. Thus, as medical tourism continues to grow, the demand for cystoscopy and ureteroscopy is expected to rise, providing significant opportunities for healthcare providers and medical equipment manufacturers to expand their reach. Additionally, the flourishing medical tourism encourages hospitals and clinics to upgrade their infrastructure and equipment to cater to international patients. Thus, India's focus on strengthening its position as a global leader in medical tourism generates significant growth opportunities for the India market in the near future.
India Cystoscopy and Ureteroscopy Market Report Segmentation Analysis
Key segments that contributed to the derivation of the India cystoscopy and ureteroscopy market analysis are product type, procedure, technology, usage type, and end user.
- In terms of product type, the India cystoscopy and ureteroscopy market is segmented into cystoscope, ureteroscope, and urology camera. The cystoscope segment held the largest share of the market in 2023.
- Based on procedure, the market is segmented into benign prostrate hyperplasia (BPH), bladder cancer, stone management, and others. The stone management segment dominated the market in 2023.
- Based on technology, the market is segmented into fiber optic, video, and others. The video segment held the largest share of the market in 2023.
- Based on usage type, the market is bifurcated into reusable and single use. The reusable segment held a larger share of the market in 2023.
- By end user, the market is categorized into hospitals, ambulatory surgical centers, and specialty clinics. The hospitals segment dominated the market in 2023.
India Cystoscopy and Ureteroscopy Market Share Analysis
The India cystoscopy and ureteroscopy market is experiencing significant growth, driven by the increasing prevalence of urological conditions such as kidney stones, bladder cancer, and urinary tract infections (UTIs). Cystoscopy and ureteroscopy procedures are becoming essential diagnostic and therapeutic tools in the healthcare sector owing to their ability to provide visual access to the bladder, urethra, ureters, and kidneys. An upsurge in the cases of these conditions, combined with benefits conferred by minimally invasive procedures, propels the adoption of cystoscopes and ureteroscopes across hospitals in India. Leading healthcare providers such as Fortis Healthcare, Max Healthcare, and Medanta – The Medicity are integrating state-of-the-art flexible ureteroscopes and advanced cystoscopy techniques into their urological departments. These technologies offer superior precision, reduced recovery times, and better patient outcomes compared to traditional methods. For example, Fortis and Max Healthcare have implemented these advanced tools for treating kidney stones, one of the most common urological conditions in India. Medanta in Gurugram uses cutting-edge cystoscopy and ureteroscopy for the diagnosis and treatment of a range of urological disorders, which further enhances its reputation for high-quality care.
India Cystoscopy and Ureteroscopy Market Report Scope
India Cystoscopy and Ureteroscopy Market Report Coverage and Deliverables
The "India Cystoscopy and Ureteroscopy Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- India cystoscopy and ureteroscopy market size and forecast for all the key market segments covered under the scope
- India cystoscopy and ureteroscopy market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST and SWOT analysis
- India cystoscopy and ureteroscopy market analysis covering key market trends, country framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the India cystoscopy and ureteroscopy market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Cystoscopy and ureteroscopy are medical procedures used to examine and treat conditions of the urinary tract focusing on different areas of the urinary system. Cystoscope and ureteroscope are thin flexible and rigid tube with light and camera attached to it which helps in visualization of the interior of bladder and urethra for treatment and diagnosis of urinary disorders.
The market is estimated to grow with a CAGR of 7.2% from 2022 to 2028.
The market segmentation by product type is led by cystoscope segment that is growing significantly due to increasing innovation in cystoscopes along with wide applications and new product launches.
Key factors that are driving growth of the market are increasing prevalence of urological diseases and development of technologically advanced and minimally invasive products fuel the growth of the market.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. India Cystoscopy and Ureteroscopy Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Pricing Analysis
5. India Cystoscopy and Ureteroscopy Market – Key Market Dynamics
5.1 India Cystoscopy and Ureteroscopy Market – Key Market Dynamics
5.2 Market Drivers
5.2.1 Increasing Prevalence of Urological Diseases
5.2.2 Development of Technologically Advanced and Minimally Invasive Products
5.3 Market Restraints
5.3.1 High Cost of Equipment and Procedures
5.4 Market Opportunities
5.4.1 Growing Medical Tourism Industry
5.5 Future Trends
5.5.1 Shift Toward Robotic-Assisted Urological Surgeries
5.6 Impact of Drivers and Restraints:
6. India Cystoscopy and Ureteroscopy Market Analysis
6.1 India Cystoscopy and Ureteroscopy Market Revenue (US$ Million), 2021–2031
7. India Cystoscopy and Ureteroscopy Market Analysis – by Product Type
7.1 Cystoscope
7.1.1 Overview
7.1.2 Cystoscope: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Ureteroscope
7.2.1 Overview
7.2.2 Ureteroscope: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Urology Camera
7.3.1 Overview
7.3.2 Urology Camera: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
8. India Cystoscopy and Ureteroscopy Market Analysis – by Procedures
8.1 Stone Management
8.1.1 Overview
8.1.2 Stone Management: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Bladder Cancer
8.2.1 Overview
8.2.2 Bladder Cancer: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Benign Prostrate Hyperplasia (BPH)
8.3.1 Overview
8.3.2 Benign Prostrate Hyperplasia (BPH): India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Others
8.4.1 Overview
8.4.2 Others: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
9. India Cystoscopy and Ureteroscopy Market Analysis – by Technology
9.1 Fiber Optic
9.1.1 Overview
9.1.2 Fiber Optic: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
9.2 Video
9.2.1 Overview
9.2.2 Video: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
9.3 Others
9.3.1 Overview
9.3.2 Others: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
10. India Cystoscopy and Ureteroscopy Market Analysis – by Usage Type
10.1 Reusable
10.1.1 Overview
10.1.2 Reusable: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
10.2 Single Use
10.2.1 Overview
10.2.2 Single Use: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
11. India Cystoscopy and Ureteroscopy Market Analysis – by End User
11.1 Hospitals
11.1.1 Overview
11.1.2 Hospitals: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
11.2 Ambulatory Surgical Centers
11.2.1 Overview
11.2.2 Ambulatory Surgical Centers: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
11.3 Specialty Centers
11.3.1 Overview
11.3.2 Specialty Centers: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
12. Company Profiles
12.1 Olympus Corp
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Karl Storz SE & Co KG
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Richard Wolf GmbH.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Ambu A/S
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 PENTAX Medical
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Advin Health Care Pvt Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Coloplast Corp
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Cook Medical Holdings LLC
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Electronics Services Centre (ESC Medicams)
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Stryker Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Rudra Surgicals
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
12.12 Laborie
12.12.1 Key Facts
12.12.2 Business Description
12.12.3 Products and Services
12.12.4 Financial Overview
12.12.5 SWOT Analysis
12.12.6 Key Developments
12.13 Teleflex Inc
12.13.1 Key Facts
12.13.2 Business Description
12.13.3 Products and Services
12.13.4 Financial Overview
12.13.5 SWOT Analysis
12.13.6 Key Developments
12.14 NIDHI MEDITECH SYSTEMS
12.14.1 Key Facts
12.14.2 Business Description
12.14.3 Products and Services
12.14.4 Financial Overview
12.14.5 SWOT Analysis
12.14.6 Key Developments
12.15 Pioneer Healthcare Technologies
12.15.1 Key Facts
12.15.2 Business Description
12.15.3 Products and Services
12.15.4 Financial Overview
12.15.5 SWOT Analysis
12.15.6 Key Developments
12.16 Boston Scientific Corp
12.16.1 Key Facts
12.16.2 Business Description
12.16.3 Products and Services
12.16.4 Financial Overview
12.16.5 SWOT Analysis
12.16.6 Key Developments
12.17 Ottomed Endoscopy
12.17.1 Key Facts
12.17.2 Business Description
12.17.3 Products and Services
12.17.4 Financial Overview
12.17.5 SWOT Analysis
12.17.6 Key Developments
12.18 Becton Dickinson and Co
12.18.1 Key Facts
12.18.2 Business Description
12.18.3 Products and Services
12.18.4 Financial Overview
12.18.5 SWOT Analysis
12.18.6 Key Developments
12.19 SCHÖLLY FIBEROPTIC GMBH
12.19.1 Key Facts
12.19.2 Business Description
12.19.3 Products and Services
12.19.4 Financial Overview
12.19.5 SWOT Analysis
12.19.6 Key Developments
12.20 MicroPort Scientific Corp
12.20.1 Key Facts
12.20.2 Business Description
12.20.3 Products and Services
12.20.4 Financial Overview
12.20.5 SWOT Analysis
12.20.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. India Cystoscopy and Ureteroscopy Market Segmentation
Table 2. India Cystoscopy and Ureteroscopy Market – Pricing Analysis 2023 (US$/Unit)
Table 3. India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million) – by Product Type
Table 4. India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million) – by Procedures
Table 5. India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million) – by Technology
Table 6. India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million) – by Usage Type
Table 7. India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million) – by End User
Table 8. Glossary of Terms, India Cystoscopy and Ureteroscopy Market
List of Figures
Figure 1. India Cystoscopy and Ureteroscopy Market Segmentation, by Country
Figure 2. PEST Analysis
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. India Cystoscopy and Ureteroscopy Market Revenue (US$ Million), 2021–2031
Figure 5. India Cystoscopy and Ureteroscopy Market Share (%) – by Product Type, 2023 and 2031
Figure 6. Cystoscope: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 7. Ureteroscope: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Urology Camera: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. India Cystoscopy and Ureteroscopy Market Share (%) – by Procedures, 2023 and 2031
Figure 10. Stone Management: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Bladder Cancer: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Benign Prostrate Hyperplasia (BPH): India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Others: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. India Cystoscopy and Ureteroscopy Market Share (%) – by Technology, 2023 and 2031
Figure 15. Fiber Optic: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. Video: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 17. Others: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 18. India Cystoscopy and Ureteroscopy Market Share (%) – by Usage Type, 2023 and 2031
Figure 19. Reusable: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 20. Single Use: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 21. India Cystoscopy and Ureteroscopy Market Share (%) – by End User, 2023 and 2031
Figure 22. Hospitals: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 23. Ambulatory Surgical Centers: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
Figure 24. Specialty Centers: India Cystoscopy and Ureteroscopy Market – Revenue and Forecast to 2031 (US$ Million)
The List of Companies - India Cystoscopy and Ureteroscopy Market
- Olympus Corp
- Karl Storz SE & Co KG
- Richard Wolf GmbH
- Ambu A/S
- PENTAX Medical
- Advin Health Care Pvt Ltd
- Coloplast Corp
- Cook Medical Holdings LLC
- Electronics Services Centre (ESC Medicams)
- Stryker Corp
- Rudra Surgicals
- Laborie
- Teleflex Inc
- NIDHI MEDITECH SYSTEMS
- Pioneer Healthcare Technologies
- Boston Scientific Corp
- Ottomed Endoscopy
- Becton Dickinson and Co
- SCHÖLLY FIBEROPTIC GMBH
- MicroPort Scientific Corp
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.